Investigating the Correlation Between THBS2 Expression and Metastasis in Breast Cancer: An Immunohistochemical Analysis

Sivakumar; Shankar Srinivasan

doi:10.56501/intjclinicopatholcorrel.v8i2.1195

Authors

Sivakumar Private practitioner, Chintadripet, Chennai.
Shankar Srinivasan Private Practitioner

DOI:

https://doi.org/10.56501/intjclinicopatholcorrel.v8i2.1195

Abstract

Thrombospondin-2 (THBS2) plays a pivotal role in regulating tumor progression and metastasis. This study investigates the expression of THBS2 in breast cancer tissue and its correlation with tumor grade and localization in core and marginal regions of the tumor. An observational, retrospective study was conducted on 100 archived breast cancer tissue specimens, comprising 48 grade 1, 37 grade 2, and 15 grade 3 tumors. Immunohistochemical analysis was performed to evaluate THBS2 expression, and the extent and intensity of staining were scored by two independent observers. Statistical comparisons between core and marginal regions, as well as between tumor grades, were analyzed.

Results demonstrated a significant increase in THBS2 expression with tumor grade, with grade 3 tumors showing the highest levels of positivity. Additionally, marginal tissue regions exhibited consistently higher THBS2 staining compared to core regions, irrespective of tumor grade. These findings suggest that THBS2 is involved in tumor invasion and metastasis, with a pronounced role at the invasive tumor margins. The differential expression of THBS2 across tumor grades and tissue regions highlights its potential as a biomarker for breast cancer aggressiveness and metastatic potential.

This study underscores the need for further investigation into the mechanistic role of THBS2 in breast cancer progression and its potential as a therapeutic target.

Publication Facts

This article

Author statements

Data availability

N/A

16%

External funding

No

32%

Competing interests

N/A

11%

This journal

Other journals

Articles accepted

18%

33%

Days to publication

9

145

Indexed in

—

Editor & editorial board: profiles
Academic society: N/A
Publisher: MM Publications

References

Lemij AA, Bastiaannet E, De Glas NA, van den Bos F, Portielje JE, Liefers GJ, Derks MG. Breast cancer in the older population: a global challenge—an epidemiological perspective. Annals of Breast Surgery. 2023 Jun 30;7. http://dx.doi.org/10.21037/abs-21-89

Arvelo F, Sojo F, Cotte C. Cancer and the metastatic substrate. ecancermedicalscience. 2016;10. https://doi.org/10.3332/ecancer.2016.701

Liao X, Wang W, Yu B, Tan S. Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: An integrative pan-cancer analysis. Cancer cell international. 2022 Jun 14;22(1):213. http://dx.doi.org/10.1186/s12935-022-02622-x

Huang J, Wang C, Hou Y, Tian Y, Li Y, Zhang H, Zhang L, Li W. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway. Biomedicine & Pharmacotherapy. 2023 Nov 1;167:115455. http://dx.doi.org/10.1016/j.biopha.2023.115455

Lepucki A, Orlińska K, Mielczarek-Palacz A, Kabut J, Olczyk P, Komosińska-Vassev K. The role of extracellular matrix proteins in breast cancer. Journal of Clinical Medicine. 2022 Feb 25;11(5):1250. http://dx.doi.org/10.3390/jcm11051250

Wang J, Zhan X, Luo Q, Kuang Y, Liang X, Wang J, Tao X, Sun E, Chen B. Comprehensive Analysis of the Expression and Prognostic Significance of THBSs in Breast Cancer.http://dx.doi.org/10.21203/rs.3.rs-620437/v1

Yang H, Sun B, Fan L, Ma W, Xu K, Hall SR, Wang Z, Schmid RA, Peng RW, Marti TM, Gao W. Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma. Theranostics. 2022;12(7):3104. http://dx.doi.org/10.7150/thno.69590

Qu HL, Hasen GW, Hou YY, Zhang CX. THBS2 promotes cell migration and invasion in colorectal cancer via modulating Wnt/β‐catenin signaling pathway. The Kaohsiung Journal of Medical Sciences. 2022 May;38(5):469-78. http://dx.doi.org/10.1002/kjm2.12528

Drev D, Bileck A, Erdem ZN, Mohr T, Timelthaler G, Beer A, Gerner C, Marian B. Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction. Clinical Proteomics. 2017 Dec;14:1-6. http://dx.doi.org/10.1186/s12014-017-9168-7

Qian Z, Zhang G, Song G, Shi J, Gong L, Mou Y, Han Y. Integrated analysis of genes associated with poor prognosis of patients with colorectal cancer liver metastasis. Oncotarget. 2017 Apr 4;8(15):25500. http://dx.doi.org/10.18632/oncotarget.16064

Liu Y, Lv H, Liu X, Xu L, Li T, Zhou H, Zhu H, Hao C, Lin C, Zhang Y. The RP11-417E7. 1/THBS2 signaling pathway promotes colorectal cancer metastasis by activating the Wnt/β-catenin pathway and facilitating exosome-mediated M2 macrophage polarization. Journal of Experimental & Clinical Cancer Research. 2024 Jul 17;43(1):195. https://doi.org/10.1186/s13046-024-03107-7

Weng TY, Wang CY, Hung YH, Chen WC, Chen YL, Lai MD. Differential expression pattern of THBS1 and THBS2 in lung cancer: clinical outcome and a systematic-analysis of microarray databases. PloS one. 2016 Aug 11;11(8):e0161007. http://dx.doi.org/10.1371/journal.pone.0161007

Deng B, Liu XP, Wang X. Prognostic and immunological role of THBS2 in colorectal cancer. BioMed Research International. 2021;2021(1):1124985. http://dx.doi.org/10.1155/2021/1124985